Walgreens Boots Alliance's fourth-quarter earnings per share and revenue, while lower than last year, exceeded Wall Street's expectations, according to CNBC.

Walgreens is shutting down all 17 of its healthcare clinics in Kansas City, Mo., at the end of the year, according to KCTV 5.

Amgen will sell its cholesterol drug Repatha exclusively at the lower list price it introduced in 2018, which is 60 percent lower than the drug's original $14,100 price tag.

The Drug Enforcement Administration is expanding National Prescription Drug Take Back Day to include vaping products in the wake of a rising number of vaping-related deaths and illnesses, according to NPR.

A report from the nonpartisan Congressional Research Service found House Speaker Nancy Pelosi's drug pricing bill may be ruled unconstitutional if taken to court, according to STAT.

St. Clare Hospital in Fenton, Mo., will be the first hospital in the St. Louis region to receive drugs from Civica Rx.

One in four new drugs approved by regulators in the last decade were supported by taxpayer dollars, according to a study published in The BMJ.

The Drug Enforcement Administration proposed a new rule Oct. 23 aimed at preventing drugmakers from overproducing opioids.

Vertex Pharmaceuticals reached a deal with the U.K. government to supply its cystic fibrosis drugs, ending a four-year pricing dispute, according to STAT.

With profit margins on core services shrinking, nonprofit hospitals will rely more heavily on income from outpatient specialty drugs, but that strategy poses risks, according to a new report from Moody's Investors Service.